OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)
Close on Nov 17, 2026Market cap $1.21BP/E –Yield –
OPKO Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
OPKO Health's operating cash flow for the twelve months ending Jun 30, 2026 was -$123.38M. For fiscal 2025 it was -$178.54M. The highest annual figure on record is $164.02M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$178.54M | – |
| FY2024 | Dec 31, 2024 | -$183.49M | – |
| FY2023 | Dec 31, 2023 | -$28.20M | – |
| FY2022 | Dec 31, 2022 | -$95.19M | -348.3% |
| FY2021 | Dec 31, 2021 | $38.34M | -2.9% |
| FY2020 | Dec 31, 2020 | $39.48M | – |
| FY2019 | Dec 31, 2019 | -$172.52M | – |
| FY2018 | Dec 31, 2018 | -$109.14M | – |
| FY2017 | Dec 31, 2017 | -$92.08M | -387.3% |
| FY2016 | Dec 31, 2016 | $32.05M | -80.5% |
| FY2015 | Dec 31, 2015 | $164.02M | – |
| FY2014 | Dec 31, 2014 | -$90.38M | – |
| FY2013 | Dec 31, 2013 | -$55.65M | – |
| FY2012 | Dec 31, 2012 | -$25.42M | – |
| FY2011 | Dec 31, 2011 | -$18.50M | – |
| FY2010 | Dec 31, 2010 | -$18.71M | – |
| FY2009 | Dec 31, 2009 | -$23.46M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$43.50M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$25.92M | – |
| Q3 FY2025 | Sep 30, 2025 | -$34.65M | – |
| Q2 FY2025 | Jun 30, 2025 | -$83.42M | – |
| Q1 FY2025 | Mar 31, 2025 | -$34.55M | – |
| Q4 FY2024 | Dec 31, 2024 | -$44.41M | – |
| Q3 FY2024 | Sep 30, 2024 | -$77.08M | -332.8% |
| Q2 FY2024 | Jun 30, 2024 | -$26.44M | – |
| Q1 FY2024 | Mar 31, 2024 | -$35.57M | – |
| Q4 FY2023 | Dec 31, 2023 | -$38.29M | – |
| Q3 FY2023 | Sep 30, 2023 | $33.11M | – |
| Q2 FY2023 | Jun 30, 2023 | -$365.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$22.65M | – |
| Q4 FY2022 | Dec 31, 2022 | -$31.62M | – |
| Q3 FY2022 | Sep 30, 2022 | -$32.24M | -196.5% |
| Q2 FY2022 | Jun 30, 2022 | -$11.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.86M | -176.3% |
| Q4 FY2021 | Dec 31, 2021 | -$5.64M | -116.5% |
| Q3 FY2021 | Sep 30, 2021 | $33.40M | -47.0% |
| Q2 FY2021 | Jun 30, 2021 | -$15.45M | – |
| Q1 FY2021 | Mar 31, 2021 | $26.04M | – |
| Q4 FY2020 | Dec 31, 2020 | $34.26M | – |
| Q3 FY2020 | Sep 30, 2020 | $63.01M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.42M | – |
| Q1 FY2020 | Mar 31, 2020 | -$43.37M | – |
| Q4 FY2019 | Dec 31, 2019 | -$46.04M | – |
| Q3 FY2019 | Sep 30, 2019 | -$23.87M | – |
| Q2 FY2019 | Jun 30, 2019 | -$53.63M | – |
| Q1 FY2019 | Mar 31, 2019 | -$48.99M | – |
| Q4 FY2018 | Dec 31, 2018 | -$34.66M | -1742.6% |
| Q3 FY2018 | Sep 30, 2018 | -$21.88M | – |
| Q2 FY2018 | Jun 30, 2018 | -$17.08M | – |
| Q1 FY2018 | Mar 31, 2018 | -$35.52M | – |
| Q4 FY2017 | Dec 31, 2017 | $2.11M | -93.0% |
| Q3 FY2017 | Sep 30, 2017 | -$37.61M | – |
| Q2 FY2017 | Jun 30, 2017 | -$22.66M | – |
| Q1 FY2017 | Mar 31, 2017 | -$33.92M | – |
| Q4 FY2016 | Dec 31, 2016 | $30.31M | – |
| Q3 FY2016 | Sep 30, 2016 | -$31.90M | – |
See a number that looks wrong?